Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Anti-Interleukin-1 in Diabetes Action (AIDA)

This study has been completed.
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Oeresund Diabetes Academy
Information provided by (Responsible Party):
Lise Tarnow, Steno Diabetes Center
ClinicalTrials.gov Identifier:
NCT00711503
First received: July 3, 2008
Last updated: August 31, 2012
Last verified: August 2012